6535 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Lumosa Therapeutics Co., Ltd. is a drug development company, which engages in the business of developing drugs for the central nervous system, oncology, and inflammatory diseases. It operates through the following geographical segments: Taiwan, Asia, America, and Europe. The company was founded on November 13, 2000 and is headquartered in Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6535 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company